Autoimmune Diseases

Neurologic Manifestations of Autoimmune Diseases


Publishing date
01 Apr 2012
Status
Published
Submission deadline
01 Oct 2011

1Rheumatology Unit, Department of Medicine, Faculty of Medical Science, State University of Campinas, 13087-500 Campinas, SP, Brazil

2Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Aviv University, Israel

3Reumatology Division, Clínica de Oncologia (CLION), 41810-570 Salvador, BA, Brazil


Neurologic Manifestations of Autoimmune Diseases

Description

Autoimmune diseases have a broad spectrum of clinical manifestations. Among the most challenging of these to diagnose and treat are those stemming from central or peripheral neurological involvement.

We invite investigators to submit original research as well as review articles exploring the diversity of neurological manifestations in autoimmune diseases of humans and in animal models. Potential topics include, but are not limited to:

  • Antiphospholipid syndrome
  • Hashimoto's thyroiditis
  • Primary Sjogren's syndrome
  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • CNS angiitis
  • ANCA associated angiitis
  • Systemic sclerosis
  • Inflammatory myopathies
  • Multiple sclerosis

Articles published in this special issue will not be subject to the journal's Article Processing Charges.

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ad/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

Autoimmune Diseases
 Journal metrics
See full report
Acceptance rate-
Submission to final decision-
Acceptance to publication-
CiteScore4.600
Journal Citation Indicator0.400
Impact Factor4.0
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.